Latest news for Foran Mining (OTC:FMCXF) Stock

Foran Mining Corp is a zinc-copper exploration and development company with projects located along the Flin Flon Greenstone Belt. Its project portfolio comprises McIlvenna Bay, Bigstone, VMS Primer, Hanson Lake Project, and others projects.

News

Movers & Shakers

Intraday Update

Markets

Movers

Trading Ideas

General

ACRX

ACTG

ALNA

AQMS

ASDN

AWSM

BARRF

BBGI

BCOR

BKPPF

CADMF

CASA

CCGM

CELC

COCP

CRBP

DPWW

DXBRF

EMERALD HEALTH THERAPUTCS by Emerald Health Therapeutics Inc.

EMHTF

ENLC

EXPE

FIXX

FLOOF

FPPP

GBLX

GENGF

GGTTF

GREEN SPIRIT INDUSTRIES by Green Spirit Industries Inc.

GSRX

GYNAF

HNRG

ICNAF

INQD

ITKG

ITRM

JAMN

JBZY

KERN

KGET

KOPN

LATF

LOPE

LTRPA

MFCSF

MOSY

MPLX

NLSN

NVDEF

OBSV

OCGN

ONTX

OPGN

OYST

PBYI

PLPL

PNBK

PRTY

PVDG

QBIO

RAIL

RMNI

RAVENQUEST BIOMED INC by Ravenquest Biomed Inc.

RVVQF

RYES

SLMBP

SNCA

SRRA

SRTS

SVVC

SWIR

SWRM

SYATF

TLCC

TMDX

TOPS

TPIC

TRIP

TVOG

TWSI

UMRX

UPWK

UVSE

UWEFF

VISL

WCTXF

WMLLF

WORK

SIRZF

TGAFF

FMCXF

Stocks That Hit 52-Week Lows On Thursday

FORAN MINING CORP by Foran Mining Corporation

Foran Mining Corp

Fairfax Financial (Prem Watsa) 2023 Letter To Shareholders

ATUSF

CIBEY

CMGGF

CSCO

EGFEF

EGFEY

EXCE

FAXRF

FAXXF

FFHPF

FFXDF

FFXXF

FMEGF

FRFFF

FRFGF

FRFHF

FRFXF

FRFZF

FXFHF

FXFLF

HZNOF

KODK

NVDA

ORLA

STZHF

Small Cap

Press Releases

Tesla Winter Drilling Expands Strike Length Beyond 1,000m

Foran Showcases TruScan™ Technology in Latest Video

Foran Announces Results of Annual and Special Meeting

Foran Unveils Inaugural Sustainability Report

Foran Announces Additional Winter Expansion Drill Results at the Tesla Zone

Foran Announces the Appointment of Marie Inkster to its Board of Directors

Nickel's Bumpy Ride in 2023 Being Followed by Significant Rebound in 2024

Financing

Foran Announces Strategic Investments by Fairfax Financial, Agnico Eagle and other Cornerstone Investors, Formal Construction Decision for Phase 1 at McIlvenna Bay and Advances Planning for Phase 2

Foran Announces Upsize to Previously Announced Private Placements to C$360M

Why Gold and Copper Mining Markets Are Projected to Increase in Coming Years as Demand Jumps

BBBXF

CPPKF

CSE:FNI

FNICF

SSRM

TSX:AGI

TSX:FDY

TSX:FOM

TSX:HBM

TSX:SSRM

TSXV:BBB

TSXV:NCX

TSXV:NWST

Foran Mining

Scotiabank

BMO Capital

Scotiabank analyst Eric Winmill maintains Foran Mining (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FMCXF#OTC">FMCXF</a>) with a Outperform and lowers the price target from C$4.25 to C$4.

Price Target

Analyst Ratings

Scotiabank Maintains Outperform on Foran Mining, Lowers Price Target to $4

&nbsp;

<h2>Upgrades</h2>

<ul>
	<li>For Okta Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OKTA#NASDAQ">OKTA</a>), Needham upgraded the previous rating of Hold to Buy. In the second quarter, Okta showed an EPS of $0.11, compared to $0.07 from the year-ago quarter. The stock has a 52-week-high of $294.00 and a 52-week-low of $185.05. At the end of the last trading period, Okta closed at $264.76.</li>
	<li>According to JP Morgan, the prior rating for UCB SA (OTC:<a class="ticker" href="https://www.benzinga.com/stock/UCBJY#OTC">UCBJY</a>) was changed from Neutral to Overweight. The stock has a 52-week-high of $59.86 and a 52-week-low of $44.41. At the end of the last trading period, UCB closed at $57.52.</li>
</ul>

<a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">See all analyst ratings upgrades.</a>

&nbsp;

<h2>Downgrades</h2>

<ul>
	<li>Janney Montgomery Scott downgraded the previous rating for Texas Capital Bancshares Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCBI#NASDAQ">TCBI</a>) from Buy to Neutral. In the second quarter, Texas Capital Bancshares showed an EPS of $1.31, compared to $0.26 from the year-ago quarter. At the moment, the stock has a 52-week-high of $93.26 and a 52-week-low of $29.45. Texas Capital Bancshares closed at $67.10 at the end of the last trading period.</li>
	<li>According to B of A Securities, the prior rating for Alkermes PLC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALKS#NASDAQ">ALKS</a>) was changed from Neutral to Underperform. In the second quarter, Alkermes showed an EPS of $0.30, compared to $0.06 from the year-ago quarter. At the moment, the stock has a 52-week-high of $31.52 and a 52-week-low of $15.35. Alkermes closed at $31.25 at the end of the last trading period.</li>
	<li>According to William Blair, the prior rating for Assembly Biosciences Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASMB#NASDAQ">ASMB</a>) was changed from Outperform to Market Perform. In the second quarter, Assembly Biosciences showed an EPS of $0.55, compared to $0.19 from the year-ago quarter. The current stock performance of Assembly Biosciences shows a 52-week-high of $21.93 and a 52-week-low of $3.32. Moreover, at the end of the last trading period, the closing price was at $3.90.</li>
</ul>

<a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">See all analyst ratings downgrades.</a>

&nbsp;

<h2>Initiations</h2>

<ul>
	<li>With a Buy rating, Craig-Hallum initiated coverage on Teradata Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TDC#NYSE">TDC</a>). The price target seems to have been set at $88.00 for Teradata. For the second quarter, Teradata had an EPS of $0.74, compared to year-ago quarter EPS of $0.24. The stock has a 52-week-high of $59.58 and a 52-week-low of $17.99. At the end of the last trading period, Teradata closed at $54.66.</li>
	<li>With a Buy rating, B. Riley Securities initiated coverage on RumbleON Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RMBL#NASDAQ">RMBL</a>). The price target seems to have been set at $70.00 for RumbleON. In the second quarter, RumbleON showed an EPS of $1.05, compared to $1.79 from the year-ago quarter. The current stock performance of RumbleON shows a 52-week-high of $64.13 and a 52-week-low of $25.38. Moreover, at the end of the last trading period, the closing price was at $36.44.</li>
	<li>B. Riley Securities initiated coverage on Portage Biotech Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRTG#NASDAQ">PRTG</a>) with a Buy rating. The price target for Portage Biotech is set to $40.00. Portage Biotech earned $0.25 in the first quarter. At the moment, the stock has a 52-week-high of $44.98 and a 52-week-low of $13.40. Portage Biotech closed at $21.61 at the end of the last trading period.</li>
	<li>Cantor Fitzgerald initiated coverage on Regulus Therapeutics Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGLS#NASDAQ">RGLS</a>) with an Overweight rating. The price target for Regulus Therapeutics is set to $2.00. In the second quarter, Regulus Therapeutics showed an EPS of $0.08, compared to $0.23 from the year-ago quarter. At the moment, the stock has a 52-week-high of $2.32 and a 52-week-low of $0.42. Regulus Therapeutics closed at $0.81 at the end of the last trading period.</li>
	<li>With a Buy rating, Deutsche Bank initiated coverage on Blade Air Mobility Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLDE#NASDAQ">BLDE</a>). The price target seems to have been set at $15.00 for Blade Air Mobility. In the third quarter, Blade Air Mobility earned $0.15. At the moment, the stock has a 52-week-high of $11.87 and a 52-week-low of $6.41. Blade Air Mobility closed at $8.85 at the end of the last trading period.</li>
	<li>With a Hold rating, Deutsche Bank initiated coverage on Starbucks Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBUX#NASDAQ">SBUX</a>). The price target seems to have been set at $127.00 for Starbucks. In the third quarter, Starbucks showed an EPS of $1.01, compared to $0.46 from the year-ago quarter. The current stock performance of Starbucks shows a 52-week-high of $126.32 and a 52-week-low of $81.75. Moreover, at the end of the last trading period, the closing price was at $117.45.</li>
	<li>With an Outperform rating, Baird initiated coverage on RumbleON Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RMBL#NASDAQ">RMBL</a>). The price target seems to have been set at $42.00 for RumbleON. For the second quarter, RumbleON had an EPS of $1.05, compared to year-ago quarter EPS of $1.79. The current stock performance of RumbleON shows a 52-week-high of $64.13 and a 52-week-low of $25.38. Moreover, at the end of the last trading period, the closing price was at $36.44.</li>
	<li>With an Outperform rating, Wedbush initiated coverage on Catabasis Pharmaceuticals Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CATB#NASDAQ">CATB</a>). The price target seems to have been set at $16.00 for Catabasis Pharmaceuticals. In the second quarter, Catabasis Pharmaceuticals showed an EPS of $0.89, compared to $0.53 from the year-ago quarter. The current stock performance of Catabasis Pharmaceuticals shows a 52-week-high of $10.19 and a 52-week-low of $1.20. Moreover, at the end of the last trading period, the closing price was at $9.41.</li>
	<li>Stifel initiated coverage on Materialise NV (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTLS#NASDAQ">MTLS</a>) with a Buy rating. The price target for Materialise is set to $30.00. For the second quarter, Materialise had an EPS of $0.07, compared to year-ago quarter EPS of $0.04. The stock has a 52-week-high of $87.40 and a 52-week-low of $18.52. At the end of the last trading period, Materialise closed at $22.91.</li>
	<li>Goldman Sachs initiated coverage on Enviva Partners LP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EVA#NYSE">EVA</a>) with a Neutral rating. The price target for Enviva Partners is set to $54.00. In the second quarter, Enviva Partners showed an EPS of $0.24, compared to $0.26 from the year-ago quarter. At the moment, the stock has a 52-week-high of $56.69 and a 52-week-low of $36.57. Enviva Partners closed at $53.83 at the end of the last trading period.</li>
</ul>

<a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">See all analyst ratings initiations.</a>

Upgrades

Downgrades

Initiation

ALKS

ASMB

BLDE

CATB

HENKY

MAPS

MTLS

OKTA

PRTG

RGLS

RMBL

SBUX

TCBI

UCBJY

VLTA

Benzinga's Top Ratings Upgrades, Downgrades For September 2, 2021

BMO Capital analyst Rene Cartier initiates coverage on Foran Mining (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FMCXF#OTC">FMCXF</a>) with a Outperform rating and announces Price Target of $2.75.

BMO Capital Initiates Coverage On Foran Mining with Outperform Rating, Announces Price Target of $2.75

The Only Monthly Membership With a Positive ROI!

-

-

-

-

-

-

-

The Only Monthly Membership With a Positive ROI!

-

-

-

-

-

-

-

Comments

Foran Mining

News

Latest news for Foran Mining (OTC:FMCXF) Stock

Wednesday, June 28, 2023

Thursday, September 02, 2021

Thursday, November 07, 2019